A phase I trial combining decitabine/dendritic cell vaccine targeting MAGE-A1, MAGE-A3 and NY-ESO-1 for children with relapsed or therapy-refractory neuroblastoma and sarcoma
Titel:
A phase I trial combining decitabine/dendritic cell vaccine targeting MAGE-A1, MAGE-A3 and NY-ESO-1 for children with relapsed or therapy-refractory neuroblastoma and sarcoma
Auteur:
Krishnadas, Deepa K. Shusterman, Suzanne Bai, Fanqi Diller, Lisa Sullivan, Janice E. Cheerva, Alexandra C. George, Rani E. Lucas, Kenneth G.